BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
70 hedge funds and large institutions have $509M invested in Blueprint Medicines in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
17% less capital invested
Capital invested by funds: $610M → $509M (-$101M)
Holders
70
Holding in Top 10
2
Calls
$102K
Puts
$70K
Top Buyers
1 | +$3.81M | |
2 | +$3.38M | |
3 | +$2.94M | |
4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.77M |
5 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.65M |
Top Sellers
1 | -$3.63M | |
2 | -$2.91M | |
3 | -$2.28M | |
4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$1.97M |
5 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
-$1.13M |